Qube Research & Technologies (QRT)’s Enfusion, Inc. ENFN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-401,612	Closed	-$4.48M	–	4087
2025 Q1	$4.48M	Buy	401,612 +174,036	+76%	+$1.92M	0.01%	1597
2024 Q4	$2.34M	Buy	227,576 +174,960	+333%	+$1.69M	﹤0.01%	1816
2024 Q3	$499K	Buy	+52,616	New	+$454K	﹤0.01%	2269
2023 Q2	–	Sell	-30,397	Closed	-$319K	–	3132
2023 Q1	$319K	Buy	+30,397	New	+$335K	﹤0.01%	1734

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ENFN Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 401,612 shares — an estimated $4.48M sold.

Qube Research & Technologies (QRT) first reported a position in ENFN in Q1 2023 and held it in 4 quarters. The position peaked at $4.48M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Qube Research & Technologies (QRT) reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 401,612 Enfusion, Inc. shares in Q2 2025, an estimated $4.48M.
Qube Research & Technologies (QRT) first reported a position in Enfusion, Inc. in Q1 2023 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Enfusion, Inc. position peaked at $4.48M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.